User Profile
Corporate
Careers
FAQ
Blog
Pricing
Social
General Modals
Advanced Modals
Search
Wizards
Interplay of Autophagy Regulated Cell Death and HIV Pathogenesis in Substance Use Disorders (R01, R21 Clinical Trial Not Allowed)
The notice of funding opportunity (NOFO) aims to support studies to expand our knowledge of mechanisms driving autophagy and to identify autophagy pathways that can be exploited to control HIV infection and pathogenesis of comorbities in the context of addictive substance use. The NOFO invites mechanistic studies and preclinical studies testing effects of compounds known to interfere with autophagy pathways on HIV infection and immune system. All studies must clearly address the intersection between HIV and substance use.
Although this program uses the R01 grant mechanism, it runs in parallel with a program announcement of identical scope, RFA-DA-25-010 , which uses the R21 mechanism.
Deadlines:
-
Letter of Intent Due Date(s): October 14, 2024
-
AIDS Application Due Date: November 14, 2024
RFA-DA-25-009 Expiration Date November 15, 2024
Specialties
Eligibility Requirements
Sponsor Details
Sponsor Institute/Organizations: National Institutes of Health
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Grant
Final Deadline:
Nov 14, 2024
Funding Amount:
Varies
Host Details
Affiliation: National Institutes of Health
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.
Invite Gmail Contacts